Puramed Bioscience (fka )

[BioSpecialist]

THE SAME MANAGEMENT WILL BRING THE LIPIGESIC PRODUCTS TO MARKET NEXT Q .DO YOU KNOW WHAT WILL HAPPEN WITH THE SHARE PRICE IF THEY REACH THE SAME NUMBERS WITH LIPIGESIC ??? BOOM TO ORBIT !!

MARKET CAP : $5 MIL


Product development and design packaging of all PuraMed products have been conducted entirely by the Company's two principal officers, Russell Mitchell and James Higgins: Messrs. Mitchell and Higgins have extensive and lengthy experience in new product development and marketing of non-prescription medical products and nutritional supplements and the many varied promotional activities involved in their marketing rollouts. For example, Mitchell Health Technologies served as the master broker for the launch of Quigley Corp's "Cold-Eeze" treatment for common colds, which within 18 months exceeded $70 million in annual wholesale revenues. The Company considers the long and successful professional involvement of its management team in our industry to be a valuable asset to draw upon to achieve the future growth and profitability anticipated by the Company.